Amin Daei Sorkhabi

6 ta ish

Tabriz University of Medical Sciences

1. Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis

   Navid Shomali, Behzad Baradaran, Amin Daei Sorkhabi +12

   MaqolaOAOchiq kirish20223 iqtibos

   ABIABI:AkademIndex/2026.other.047821

2. The regulatory role of autophagy-related miRNAs in lung cancer drug resistance

   Mahshid Shahverdi, Khalil Hajiasgharzadeh, Amin Daei Sorkhabi +9

   Sharh maqolaOAOchiq kirish20222 iqtibos

   ABIABI:AkademIndex/2026.other.047809

3. RETRACTED: Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies

   Navid Shomali, Marwah Suliman Maashi, Behzad Baradaran +7

   Sharh maqolaOAOchiq kirish20222 iqtibos

   ABIABI:AkademIndex/2026.other.047810

4. The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme

   Amin Daei Sorkhabi, Aila Sarkesh, Hossein Saeedi +5

   Sharh maqolaOAOchiq kirish20222 iqtibos

   ABIABI:AkademIndex/2026.other.047812

5. Cancer combination therapies by silencing of CTLA‐4, PD‐L1, and TIM3 in osteosarcoma

   Amin Daei Sorkhabi, Aila Sarkesh, Ali Fotouhi +2

   Maqola20222 iqtibos

   ABIABI:AkademIndex/2026.other.047818

6. The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies

   Amin Daei Sorkhabi, Leila Mohamed Khosroshahi, Aila Sarkesh +4

   Sharh maqolaOAOchiq kirish20232 iqtibos

   ABIABI:AkademIndex/2026.other.102935